Skip to main content

GOLDMAN SACHS GROUP INC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 886982 NEW YORK, NY

Position in PTGX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$99,639,397
+$17,538,596 QoQ
Shares Held
812,852
+4.4% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. PTGX ranks #35 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTGX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $99,639,397 812,852
2026-03-31 $82,100,801 778,945
2025-12-31 $83,946,752 961,149
2025-09-30 $51,929,060 781,711
2025-06-30 $42,961,756 777,307
2025-03-31 $26,866,446 555,551
2024-12-31 $29,285,433 758,690
2024-09-30 $36,983,520 821,856
2024-06-30 $20,469,867 590,761
2024-03-31 $15,189,406 525,040
2023-12-31 $11,813,994 515,220
2023-09-30 $7,792,945 467,203
2023-06-30 $15,445,379 559,210
2023-03-31 $10,567,350 459,450
2022-12-31 $6,728,458 616,724
2022-09-30 $6,382,175 757,079
2022-06-30 $4,998,454 631,916
2022-03-31 $8,201,781 346,359
2021-12-31 $4,228,111 123,629
2021-09-30 $7,499,014 423,195
2021-06-30 $17,590,401 391,943
2021-03-31 $10,726,070 414,134
2020-12-31 $11,124,025 551,787
2020-09-30 $4,341,663 222,080
2020-06-30 $9,360,647 530,048
2020-03-31 $449,728 63,701